Trial Profile
A retrospective chart review of ustekinumab in patients with refractory Crohn's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2016
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 30 Nov 2016 New trial record